Products (Pharmaceuticals)
The pharmaceutical arena changes often as companies look for new products, new ingredients and new delivery systems. These factors are important to provide consumers with a pharmaceutical product that can ease their symptoms with the least possible interruption to their daily routines.
Mastix Medica was created by a pharmaceutical industry executive with the goal of developing niche healthcare products in underutilized, emerging dosage forms like chewing gum and chewable tablets.
Because we make our own powdered gum base, Mastix Medica is the only gum manufacturer in the world, that can customize formulas in a cold pressed tableted gum product. Other gum products using the conventional extruded method of manufacturing often contain far less of their listed ingredients due to high temperature needed to extrude the gum. Because Mastix Medica uses a cold pressed tableting process, what is put into the gum is what shows up in the finished product. This method also ensures a higher level of content uniformity from tablet to tablet, making certain that the consumer receives the dose reflected on the package. With the manufacturing process used by Mastix Medica, active ingredients** can now be supplied to the body through the buccal cavity – simply by chewing gum.
Chewing gum products have many advantages versus other oral dosage forms:
Fast acting: many times faster absorption than tablets or capsules
Convenient and discreet: does not require any liquid for swallowing
Widely acceptable and very familiar to consumers
High bioavailability of ingredients: avoid hepatic first pass metabolism in stomach and liver
Increased compliance in people with swallowing difficulties like geriatrics or children
Chewing gum products made using a direct compression tableting offers significant advantages over conventionally manufactured gum products made using an extrusion process:
Active ingredients and supplements released faster
Active ingredients and supplements remain active unlike extrusion products that use high heat during the process which can inactivate the active ingredients
High content uniformity of active ingredients and supplements from tablet to tablet
Mastix Medica will be available to develop and produce both Rx and OTC pharmaceutical products using its unique delivery system in 2011. By beginning discussions now, you can be the first to market with a good tasting, fast acting, chewing gum pharmaceutical product.
Click here to e-mail our CEO, Robert Estey, or call him at 410-316-1080 Ext. 100.
** Not all ingredients can absorbed through the buccal cavity and will require clinical studies to support this claim.
|